Spinal Cord Injury
Spinal cord injury management has been transformed by neuromodulation, with Onward ARC-EX gaining FDA approval and multiple platforms in trials. The session covers epidural and transcutaneous spinal stimulation (Onward ARC-EX, ARC-IM, eXcelsior), robotic gait training (Lokomat, Andago, Wandercraft Atalante), neuropathic pain management in SCI, autonomic dysfunction including dysreflexia and orthostatic intolerance, regenerative approaches (Pre-IND scaffold-cell trials), and the multidisciplinary SCI care model. Discussion addresses functional electrical stimulation closed-loop systems, exoskeleton-assisted ambulation for home use, bowel and bladder management innovation, pressure-injury prevention with sensor technology, and quality-of-life outcomes beyond walking.
- Onward ARC-EX FDA approval
- Robotic gait training
- Neuropathic pain in SCI
- Autonomic dysfunction
- Regenerative scaffold trials
- Closed-loop FES
- Home exoskeleton use
- Pressure-injury sensor tech
Explore the full GCNN 2027 program
- 01Stroke & Cerebrovascular Disease
- 02Alzheimer’s & Dementia
- 03Multiple Sclerosis
- 04Parkinson’s & Movement Disorders
- 05Epilepsy
- 06Neuromuscular Disease
- 07Headache Medicine
- 08Neuro-Oncology
- 09Clinical Neuroscience & AI
- 11Traumatic Brain Injury
- 12Sleep Disorders
- 13Neuropathic Pain
- 14Cerebellar & Ataxia Disorders
- 15Functional Neurological Disorders
- 16Pediatric Neurology
- 17Neuroimmunology
- 18Brain-Computer Interfaces
- 19Migraine
- 20Cluster Headache
- 21Dementia with Lewy Bodies
- 22Frontotemporal Dementia
- 23Huntington Disease
- 24ALS
- 25Tremor & Dystonia
- 26Restless Legs Syndrome
- 27Neuroinfectious Disease
- 28Brain Tumors
- 29Vestibular Disorders
- 30Autonomic Disorders
- 31Functional Imaging
- 32Neuro-Ophthalmology
- 33Neuropsychology
- 34Movement Disorder Surgery
- 35Genetic Counselling